Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinosarcoma × rebastinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1 Breast 1

Conditions

Neoplasm Metastasis 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Mesothelioma 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Paclitaxel 2 Carboplatin 2 rucaparib 1 ribociclib 1 rebastinib 1 Fulvestrant 1 DCC-2036 1 Cisplatin 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03601897 2024-12-27

A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

Deciphera Pharmaceuticals, LLC

Phase 1/2 Terminated

177 enrolled 25 charts

BreastGynecologicSarcoma

Breast Neoplasms, Carcinosarcoma, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡